- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
BRD1 Antibody (N-term)Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP8048a | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
BRD1 Antibody (N-term) - Product info | |
| Application | IHC, WB
|
| Primary Accession | O95696 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 119520 Da |
BRD1 Antibody (N-term) - Additional info | |
| Gene ID 23774 | |
| Other Names BRD1; BRL; BRPF2; Bromodomain-containing protein 1; BR140-like protein; Bromodomain and PHD finger-containing protein 2 | |
| Target/Specificity This BRD1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1~31 amino acids from the N-terminal region of human BRD1. | |
| Dilution IHC~~1:50~100 WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions BRD1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
BRD1 Antibody (N-term) - Protein Information | |
| Name BRD1 | |
| Synonyms BRL, BRPF2 | |
| Function Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity | |
| Cellular Location Nucleus. | |
| Tissue Location Highly expressed in testis. | |
BRD1 Antibody (N-term) - Related products
AP14018a: BRD1 Antibody (N-term)
AP8048a: BRD1 Antibody (N-term)
AP8048b: BRD1 Antibody (C-term)
BRD1 Antibody (N-term) - Application data
-
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.
-
BRD1 Antibody (H8) (Cat. #AP8048a) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the BRD1 antibody detected the BRD1 protein (arrow).
BRD1 Antibody (N-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a protein of unknown function. The protein contains a bromodomain, a sequence motif often found in transcriptional coactivators, and localizes to the nucleus in testis and several other cell types.
REFERENCES
McCullagh, P., et al., Oncogene 18(52):7442-7452 (1999). Dunham, I., et al., Nature 402(6761):489-495 (1999). Haynes, S.R., et al., Nucleic Acids Res. 20 (10), 2603 (1992).
